A Scoping Review of Transition to Adult Care in Pediatric-Onset Multiple Sclerosis: An Opportunity to Advance

Claudia Gambrah-Lyles1, Kelsey Barter1, Michelle Doering2

  • 1Division of Pediatric and Developmental Neurology, Department of Neurology, Washington University in St. Louis School of Medicine, St. Louis, Missouri.

Pediatric Neurology
|December 13, 2025
PubMed

Insights

Transitioning youth with pediatric-onset multiple sclerosis (POMS) to adult care lacks sufficient evidence. More research is needed to develop and evaluate tailored strategies for successful POMS care transitions.

Area of Science:

  • Neurology
  • Immunology
  • Pediatric Healthcare

Background:

  • Pediatric-onset multiple sclerosis (POMS) is a severe neurological condition affecting up to 10% of MS patients.
  • POMS presents with a more aggressive disease course and earlier disability progression compared to adult-onset MS.
  • Effective transition-to-adult care is crucial for long-term health outcomes in youth with POMS.

Purpose of the Study:

  • To synthesize existing literature on transition-to-adult care for POMS.
  • To contextualize POMS transition within broader pediatric chronic illness care.
  • To identify research gaps in POMS transition care.

Main Methods:

  • A scoping review guided by Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) standards.
  • Searches conducted across major databases (PubMed, Scopus, Ovid Medline, Web of Science, Embase) in February 2025.
  • Two independent reviewers screened titles, abstracts, and full texts.

Main Results:

  • 12 articles specifically addressed POMS transition out of 96 included.
  • Limited evidence exists on transition strategies, with inconsistent definitions and outcome measures.
  • POMS-specific barriers include cognitive issues, symptom fluctuation, and psychosocial complexity.

Conclusions:

  • The evidence base for interventions supporting POMS transition-to-adult care is limited.
  • There is a critical need for targeted research to develop and evaluate effective transition strategies.
  • Future strategies should integrate general care plan frameworks with POMS-specific needs.
Abstract

Related Concept Videos

Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
11.7K
Documentation in Long-Term and Home Healthcare Setting01:29

Documentation in Long-Term and Home Healthcare Setting

Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
1.5K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
367
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20